Wenxia Peng

745 total citations
9 papers, 93 citations indexed

About

Wenxia Peng is a scholar working on Oncology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Wenxia Peng has authored 9 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Hepatology. Recurrent topics in Wenxia Peng's work include Liver physiology and pathology (3 papers), Cancer Treatment and Pharmacology (2 papers) and Parasites and Host Interactions (2 papers). Wenxia Peng is often cited by papers focused on Liver physiology and pathology (3 papers), Cancer Treatment and Pharmacology (2 papers) and Parasites and Host Interactions (2 papers). Wenxia Peng collaborates with scholars based in China. Wenxia Peng's co-authors include Xue He, Yinong Duan, Xiaolei Sun, Jinling Chen, Lingbo Zhang, Jianxin Wang, Jing Pan, Pei Shen, Dandan Zhu and Qun Ji and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cellular Signalling.

In The Last Decade

Wenxia Peng

7 papers receiving 93 citations

Peers

Wenxia Peng

IMMUN

MB

PARAS

HEPAT

BIOMA

Fungai Musaigwa South Africa

Brian Holloway United States

Hanna Sjoberg United Kingdom

Aude-Anaïs Olijnik United Kingdom

Eleanor C Williams United Kingdom

Pamela Caudana France

Qi He China

Liana Mackiewicz Australia

Ahmad Hosseinzadeh Adli Iran

Nicolas Soriano France

Fungai Musaigwa South Africa

Wenxia Peng

14 ×0.6

IMMUN

25 ×1.1

MB

50 ×2.3

PARAS

8 ×0.4

HEPAT

1 ×0.1

BIOMA

Citations per year, relative to Wenxia Peng Wenxia Peng (= 1×) peers Fungai Musaigwa

Countries citing papers authored by Wenxia Peng

Since Specialization

Citations

This map shows the geographic impact of Wenxia Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxia Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxia Peng more than expected).

Fields of papers citing papers by Wenxia Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxia Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxia Peng. The network helps show where Wenxia Peng may publish in the future.

Co-authorship network of co-authors of Wenxia Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxia Peng. A scholar is included among the top collaborators of Wenxia Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxia Peng. Wenxia Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Li, Bin, Tiantian Liu, Mingchuan Zhao, et al.. (2025). MYC amplification sensitizes TNBC to CHK1 inhibitors. Cellular Signalling. 131. 111709–111709.

2.

Ye, Long‐Yun, Mengdi Yang, Wenxia Peng, et al.. (2025). Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. Journal of Experimental & Clinical Cancer Research. 44(1). 304–304.

3.

Wang, Leiping, Jun Cao, Chunlei Li, et al.. (2021). Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial. Investigational New Drugs. 40(2). 330–339. 26 indexed citations

4.

Peng, Wenxia, et al.. (2021). Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53gene mutation: A case report and review of literature. World Journal of Clinical Cases. 9(5). 1184–1195. 1 indexed citations

5.

Wang, Leiping, Yannan Zhao, Ting Li, et al.. (2020). Efficacy and safety of liposomal mitoxantrone (Lipo-MIT) in advanced breast cancer (ABC): A randomized, open label, active-controlled, single-center, phase II clinical trial.. Journal of Clinical Oncology. 38(15_suppl). 1093–1093. 2 indexed citations

6.

Liu, Haipeng, Ruijuan Zheng, Peng Wang, et al.. (2017). IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation. PLoS ONE. 12(1). e0169922–e0169922. 23 indexed citations

7.

Wang, Jianxin, Wenxia Peng, Jinrong Feng, et al.. (2016). Recombinant T2 RNase protein of Schistosoma japonicum inhibits expression of α-SMA in LX-2 cells. Parasitology Research. 115(10). 4055–4060. 2 indexed citations

8.

Sun, Xiaolei, Lingbo Zhang, Jianxin Wang, et al.. (2015). Schistosoma japonicum protein SjP40 inhibits TGF-β1-induced activation of hepatic stellate cells. Parasitology Research. 114(11). 4251–4257. 26 indexed citations

9.

He, Xue, Jing Bao, Jinling Chen, et al.. (2015). Adenovirus-mediated over-expression of Septin4 ameliorates hepatic fibrosis in mouse livers infected with Schistosoma japonicum. Parasitology International. 64(6). 487–492. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact